Internal Medicine · Honolulu, HI
NPI
1336536168
Since 2015
Specialty
Internal Medicine
Code 207R00000X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
1356 Lusitana St Fl 7
Honolulu, HI, 96813
Phone (808) 586-2890
Groups this clinician bills Medicare through
Medicare paid, 2024
$58K
1,237 services
Medicare patients, 2024
352
Average age 80
Drug cost, 2024
$843K
5,715 prescriptions
Company payments, 2025
$1,298
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Marissa K Takase was code 99214 (office e&m - established), 804 times for 343 patients. In total Marissa K Takase billed 1,237 services in 20 codes, and Medicare paid $58K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-09-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 804 | 343 | $43.95 | $35K |
| 99213 Office E&M - Established | Office | 102 | 83 | $43.80 | $4,468 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 86 | 79 | $13.10 | $1,127 |
| 99441 Telephone Services | Office | 40 | 40 | $38.91 | $1,556 |
| G0008 Administration of influenza virus vaccine | Office | 33 | 33 | $33.52 | $1,106 |
| 90662 Vaccine Product | Office | 33 | 33 | $81.82 | $2,700 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 26 | 26 | $10.20 | $265 |
| G0009 Administration of pneumococcal vaccine | Office | 24 | 24 | $33.52 | $804 |
| 90677 Vaccine Product | Office | 24 | 24 | $290.17 | $6,964 |
| 99442 Telephone Services | Office | 22 | 22 | $61.30 | $1,349 |
| 93000 Electrocardiogram | Office | 12 | 11 | $9.88 | $119 |
By year: 2022 $48K for 1,157 services; 2023 $91K for 1,430 services; 2024 $58K for 1,237 services.
Medicare prescription drug claims, 2024
In 2024, the drug Marissa K Takase prescribed most often to Medicare patients was Amlodipine Besylate, with 506 prescriptions and refills. In total Marissa K Takase wrote 5,715 Medicare prescriptions that cost $843K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Amlodipine Besylate Generic | 506 | 1,484 | 146 | $7,613 |
| Atorvastatin Calcium Generic | 433 | 1,268 | 125 | $16K |
| Losartan Potassium Generic | 374 | 1,063 | 106 | $8,174 |
| Pravastatin Sodium Generic | 267 | 801 | 76 | $8,963 |
| Rosuvastatin Calcium Generic | 202 | 588 | 55 | $11K |
| Levothyroxine Sodium Generic | 170 | 494 | 40 | $794 |
| Fluticasone Propionate Generic | 103 | 207 | 53 | $1,450 |
| Metformin Hcl Generic | 97 | 293 | 28 | $866 |
| Allopurinol Generic | 97 | 248 | 27 | $1,429 |
| Jardiance Empagliflozin | 94 | 220 | 27 | $126K |
| Irbesartan Generic | 91 | 273 | 25 | $5,156 |
| Bisoprolol Fumarate Generic | 82 | 246 | 23 | $3,423 |
| Metformin Hcl Er Metformin Hcl | 82 | 246 | 25 | $2,258 |
| Metoprolol Succinate Generic | 75 | 220 | 28 | $2,129 |
| Carvedilol Generic | 72 | 215 | 23 | $1,229 |
Brand drugs: 735 claims; generic drugs: 4,946 claims; opioid claims: 14.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Marissa K Takase $1,298 ($1,298 in general payments such as food, travel and fees) from 14 companies. The largest payer was Amgen Inc. with $251.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 20 | $251 |
| Novo Nordisk Inc NVO | 9 | $190 |
| GlaxoSmithKline, LLC. GSK | 10 | $188 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $145 |
| AstraZeneca Pharmaceuticals LP AZN | 6 | $126 |
| Lilly USA, LLC LLY | 4 | $85.94 |
| Merck Sharp & Dohme LLC MRK | 4 | $79.4 |
| Exact Sciences Corporation EXAS | 2 | $54.21 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 3 | $47.16 |
| Pfizer Inc. PFE | 2 | $37.75 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.